Andersen et al., 2012 - Google Patents
Cryopreservation of ovarian tissue for fertility preservation in young female oncological patientsAndersen et al., 2012
- Document ID
- 8783982530832745932
- Author
- Andersen C
- Kristensen S
- Greve T
- Schmidt K
- Publication year
- Publication venue
- Future Oncology
External Links
Snippet
Girls and women suffering from a cancer that requires treatment with gonadotoxic drugs may experience cessation of reproductive function as a side effect due to obliteration of the ovarian pool of follicles. Techniques are now available for fertility preservation, such as …
- 230000002611 ovarian 0 title abstract description 192
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Andersen et al. | Cryopreservation of ovarian tissue for fertility preservation in young female oncological patients | |
| Silber et al. | Cryopreservation and transplantation of ovarian tissue: results from one center in the USA | |
| Silber | Ovarian tissue cryopreservation and transplantation: scientific implications | |
| von Wolff et al. | Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy–a technique in its infancy but already successful in fertility preservation | |
| Kelleher et al. | Long-term outcomes of elective human sperm cryostorage | |
| Kedem et al. | Outcome of immature oocytes collection of 119 cancer patients during ovarian tissue harvesting for fertility preservation | |
| Donnez et al. | Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births | |
| Rowell et al. | Laparoscopic unilateral oophorectomy for ovarian tissue cryopreservation in children | |
| Schiff et al. | Success of testicular sperm injection and intracytoplasmic sperm injection in men with Klinefelter syndrome | |
| Grynberg et al. | Ovarian tissue and follicle transplantation as an option for fertility preservation | |
| Anderson et al. | Fertility preservation in girls and young women | |
| Meirow et al. | Ovarian tissue cryopreservation in hematologic malignancy: ten years' experience | |
| Blumenfeld et al. | Preserving fertility when choosing chemotherapy regimens–the role of gonadotropin-releasing hormone agonists | |
| Botchan et al. | Preservation of sperm of cancer patients: extent of use and pregnancy outcome in a tertiary infertility center | |
| Rodriguez-Wallberg et al. | Fertility preservation medicine: options for young adults and children with cancer | |
| Silvestris et al. | Breast cancer: an update on treatment-related infertility | |
| Takai | Recent advances in oncofertility care worldwide and in Japan | |
| Gamzatova et al. | Autotransplantation of cryopreserved ovarian tissue–effective method of fertility preservation in cancer patients | |
| Ginsberg | New advances in fertility preservation for pediatric cancer patients | |
| Skaznik-Wikiel et al. | Fertility preservation options for men and women with cancer | |
| Fabbri et al. | Autotransplantation of cryopreserved ovarian tissue in oncological patients: recovery of ovarian function | |
| Salama et al. | Advances in fertility preservation of female patients with hematological malignancies | |
| Kondapalli | Ovarian tissue cryopreservation and transplantation | |
| Kolp et al. | Autotransplantation of cryopreserved ovarian tissue: a procedure with promise, risks, and a need for a registry | |
| Ruan et al. | First pregnancy in China after ovarian tissue transplantation to prevent premature ovarian insufficiency |